Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. 1990

J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
Department of Internal Medicine, University Hospital, Zürich, Switzerland.

In 3 of 15 consecutive patients receiving a human leukocyte antigen (HLA)-identical but major ABO incompatible bone marrow transplant (BMT), pure red cell aplasia (PRA) lasting 5 to 8 months was observed. Titers of the incompatible anti-A agglutinin before infusion of the red blood cell (RBC)-depleted BMT was very high in one, and in the usual range in two patients. Decrease of agglutinin titers during the first 4 weeks after BMT were comparable between PRA patients and those of ABO-incompatible BMT recipients with timely RBC recovery. However, in PRA patients, agglutinin titers rose again and remained elevated for 19 to 28 weeks. RBC engraftment and reticulocyte recovery ultimately occurred spontaneously and coincided with the decrease of agglutinin titers below 16. These observations indicate that PRA is antibody-dependent in this setting. Furthermore, it is conceivable that cyclosporine facilitates recipient-derived antibody synthesis after major ABO-incompatible BMT.

UI MeSH Term Description Entries
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
January 1990, Acta haematologica,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
February 1991, Blood,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
March 1994, Bone marrow transplantation,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
May 1993, Transfusion,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
December 1997, Bone marrow transplantation,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
September 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
February 2002, Zhongguo shi yan xue ye xue za zhi,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
January 2022, Frontiers in immunology,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
January 1996, Transplant international : official journal of the European Society for Organ Transplantation,
J P Gmür, and J Burger, and A Schaffner, and K Neftel, and O Oelz, and D Frey, and M Metaxas
May 2021, British journal of haematology,
Copied contents to your clipboard!